CClinicalTrials.gg
Status unknownNCT02550990Updated Dec 20, 2016

Synergistic Effects of Aerobic Exercise and Cognitive Training on Cognition in Stroke Patients With Cognitive Decline

An interventional study of Cognitive training and Aerobic exercise training in Stroke Patients With Cognitive Decline, sponsored by Chang Gung Memorial Hospital. Status unknown at 6 sites in Taiwan. Open to participants aged 20 Years to 90 Years. Per ClinicalTrials.gov, last updated 2016-12-20.

Sponsored by Chang Gung Memorial Hospital · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Dec 2016), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
75
Allocation
Randomized
Ages
20 Years to 90 Years
Sex
All
01

Study summary

The purpose of this study is to determine the treatment effects of sequential combination of aerobic exercise and cognitive training on cognitive function, physiological markers, daily function, physical function, social participation and quality of life in stroke patients with cognitive decline. The investigators hypothesized that: (1) sequential training protocol can improve outcome measures compared to single mode of training; (2) these treatment effects will retain at 6-month follow-up.

02

Conditions studied

  • Stroke Patients With Cognitive Decline
03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's planned enrollment of 75 is above the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

Chang Gung Memorial Hospital is the lead sponsor of 1,064 studies on the registry; 235 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Ischemic or hemorrhagic stroke occurring at least 6 months prior to enrollment
  2. Age range from 20 to 90 years
  3. MMSE score ≥ 19
  4. MoCA\<26
  5. Self- or informant-reported memory or cognitive complaints or CDR scale ≤ 0.5
  6. Able to follow the study instruction
  7. Adequate cardiopulmonary function to perform aerobic exercise
  8. Able to walk with or without assistive devices

Exclusion criteria

Exclusion Criteria:

  1. Unstable medical history (e.g., recent myocardial infarction) that might limit participation
  2. Concomitant with other neurological disorders (e.g., Parkinson's disease, amyotrophic lateral sclerosis, multiple sclerosis)
  3. Current participation in another interventional trial
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
75 participants (estimated)

Study arms

  • Active comparator
    Cognitive training group

    One 60-min session of cognitive training. Before and after the treatment, a total of 2 evaluations were conducted, including clinical assessments and blood test (each 18c.c.). A saliva sample (2 mL) will only be collected once from each subject. A follow-up assessment of clinical outcomes will be conducted at six month after the end of the course of treatment.

    Behavioral: Cognitive training

  • Active comparator
    Aerobic exercise training group

    One 60-min session of aerobic exercise training. Before and after the treatment, a total of 2 evaluations were conducted, including clinical assessments and blood test (each 18c.c.). A saliva sample (2 mL) will only be collected once from each subject. A follow-up assessment of clinical outcomes will be conducted at six month after the end of the course of treatment.

    Behavioral: Aerobic exercise training

  • Experimental
    Sequential training group

    One 30-min session of aerobic exercise training + one 30-min session of cognitive training. Before and after the treatment, a total of 2 evaluations were conducted, including clinical assessments and blood test (each 18c.c.). A saliva sample (2 mL) will only be collected once from each subject. A follow-up assessment of clinical outcomes will be conducted at six month after the end of the course of treatment.

    Behavioral: Sequential combination of aerobic exercise and cognitive training

Interventions

  • BehavioralCognitive training
  • BehavioralAerobic exercise training
  • BehavioralSequential combination of aerobic exercise and cognitive training
06

What researchers measure

Primary outcomes

  1. Change scores of Montreal Cognitive Assessment (MoCA)

    Time frame: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)

  2. Change scores of Wechsler Memory Scale - Third Edition (WMS-III)

    Time frame: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)

  3. Change scores of Wechsler Adult Intelligence Scale - Third Edition (WAIS-III)

    Time frame: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)

  4. Change scores of Useful Field of View (UFOV)

    Time frame: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)

  5. Change scores of Stroop Color-Word test

    Time frame: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)

  6. Change scores of Dual-task test

    The dual-task tests will be assessed to determine the ability for an individual to perform 2 tasks simultaneously. The investigators will assess the dual-task performance during walking and performing box and block test. The results of the dual-task tests will provide information regarding to whether the 2 tasks compete for the same class of neural resources or one of the tasks can be carried out automatically.

    Time frame: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)

Secondary outcomes

  1. Change scores of serum BDNF level

    Time frame: Baseline, posttest (an expected average of 3 months)

  2. Change scores of Antioxidative marker

    Antioxidative markers will be used to reflect the changes on oxidative stress. In particular, we will be analyzing the total antioxidant capacity (TAC).

    Time frame: Baseline, posttest (an expected average of 3 months)

  3. Change scores of Glucose indicator

    HbA1C level will be tested to investigate the relationships between blood glucose level and aerobic exercise.

    Time frame: Baseline, posttest (an expected average of 3 months)

  4. Change scores of Plasma lipid level

    The cholesterol ratio (total cholesterol divided by high-density lipid) will be evaluated to reflect the lipid level in the blood.

    Time frame: Baseline, posttest (an expected average of 3 months)

  5. Change scores of Functional Independence Measure (FIM)

    Time frame: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)

  6. Change scores of Lawton Instrumental Activities of Daily Living Scale (Lawton IADL)

    Time frame: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)

  7. Change scores of Stroke Impact Scale (SIS)

    Time frame: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)

  8. Change scores of Caregiver Burden (CB) scale

    Time frame: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)

  9. Change scores of EuroQol (EQ)-5D questionnaire

    Time frame: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)

  10. Change scores of Timed up and go test (TUG)

    Time frame: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)

  11. Change scores of Six-minute walk test (6MWT)

    Time frame: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)

  12. Change scores of Mobility level

    Time frame: Baseline, posttest (an expected average of 3 months)

  13. Change scores of International Physical Activity Questionnaires (IPAQ)

    Time frame: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)

  14. Change scores of Fugl-Meyer Assessment (FMA)

    Time frame: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)

  15. Change scores of Rivermead Mobility Index (RMI)

    Time frame: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)

  16. Change scores of muscle strength

    We will evaluate isometric knee flexors and extensors muscle strength using handheld dynamometer. Also, we will use hand dynamometer to measure grip strength of the affected and less affected hand while the participant is seated, with the elbow at 90-degree flexion. We will record the mean value of 3 attempts.

    Time frame: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)

  17. Change scores of Community Integration Questionnaire (CIQ)

    Time frame: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)

  18. Change scores of Geriatric Depression Scale (GDS)

    Time frame: Baseline, posttest (an expected average of 3 months), follow-up (up to 9 months)

  19. Genotyping of the BDNF val66met polymorphism

    Time frame: Between baseline and posttest (an expected average of 3 months)

07

Study locations

6 of 6 sites recruiting
  • Chang Gung Memorial Hospital
    Kwei-Shan, Taoyuan 333, Taiwan
    Recruiting
  • Chiayi Chang Gung Memorial Hospital
    Chiayi City, 613, Taiwan
    Recruiting
  • Kaohsiung Chang Gung Memorial Hospital
    Kaohsiung City, 83301, Taiwan
    Recruiting
  • Keeling Chang Gung Memorial Hospital
    Keelung City, 204, Taiwan
    Recruiting
  • Taipei Chang Gung Memorial Hospital
    Taipei City, 105, Taiwan
    Recruiting
  • Taoyuan Chang Gung Memorial Hospital
    Taoyuan City, 333, Taiwan
    Recruiting
08

References and documents

Publications

  • Gibson E, Koh CL, Eames S, Bennett S, Scott AM, Hoffmann TC. Occupational therapy for cognitive impairment in stroke patients. Cochrane Database Syst Rev. 2022 Mar 29;3(3):CD006430. doi: 10.1002/14651858.CD006430.pub3. PubMed 35349186 ↗
  • Yeh TT, Wu CY, Hsieh YW, Chang KC, Lee LC, Hung JW, Lin KC, Teng CH, Liao YH. Synergistic effects of aerobic exercise and cognitive training on cognition, physiological markers, daily function, and quality of life in stroke survivors with cognitive decline: study protocol for a randomized controlled trial. Trials. 2017 Aug 31;18(1):405. doi: 10.1186/s13063-017-2153-7. PubMed 28859664 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 20, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02550990
Lead sponsor
Chang Gung Memorial Hospital
Responsible party
Sponsor
First posted
Sep 16, 2015
Start date
Sep 2015
Primary completion
Aug 2018 (estimated)
Last update
Dec 20, 2016

Study contacts

Ching-Yi Wu, ScD
Contact
cywu@mail.cgu.edu.tw
+886-3-2118800 ext. 5761

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion